£127.85

Springer Alzheimer's Disease: 2 (Topics in Medicinal Chemistry, 2)

Price data last checked 15 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£128 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 76 days · 76 data points (no recent data)

Historical
Generating forecast…
£132.39 £127.40 £128.49 £129.58 £130.66 £131.75 £132.84 26 April 2026 14 May 2026 02 June 2026 21 June 2026 10 July 2026

Price Distribution

Price distribution over 76 days • 4 price levels

Days at Price
Current Price
6 days · current 11 days 34 days 25 days 0 9 17 26 34 £128 £130 £131 £132 Days at Price

Price Analysis

Most common price: £131 (34 days, 44.7%)

Price range: £128 - £132

Price levels: 4 different prices over 76 days

Description

Alzheimer’s disease (AD) is a neurodegenerative disease that robs the minds of our elderly population. Approximately one in every eight adults over the age of 65 and nearly half of those over 85 are afflicted with this disease. The aging population in developed societies will impose an ever increasing socioeconomic threat in the future. Current medicines for AD patients are mainly symptomatic treatments and a huge unmet medical need exists to slow the progression of this disease. A great deal of research has been dedicated to understanding the pathogenesis of AD from which comes many ideas for intervening with its progression. Some of these ideas have been fast-tracked to clinical trials due to the availability of medicines with proven clinical efficacies for other diseases (e.g. atorvastatin, simvastatin, rosiglitazone and clioquinol) while others represent novel chemical entities (e.g. glycogen synthase kinase-3 inhibitors). This volume will first review existing cholinesterase inhibitors prescribed for AD patients followed by some target mechanisms with ongoing clinical trials. It offers a glimpse of what our future medicine cabinets may look like for AD patients. It also provides an interesting read on why and how current medicines for other indications could potentially be used to treat AD.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
22 January 2008
Listed Since
01 August 2007

Barcode

No barcode data available

Similar Products You Might Like

Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics
96% match

Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics

Springer

£82.10 05 Jul 2026
Pharmacological Mechanisms in Alzheimer's Therapeutics
96% match

Pharmacological Mechanisms in Alzheimer's Therapeutics

Springer

£107.98 11 Jun 2026
Recent Approaches For The Treatment Of Alzheimer’s Disease
96% match

Recent Approaches For The Treatment Of Alzheimer’s Disease

£128.47 11 Jun 2026
Computational and Experimental Studies in Alzheimer's Disease
96% match

Computational and Experimental Studies in Alzheimer's Disease

CRC Press

£107.98 17 Jun 2026
Research Progress in Alzheimer's Disease and Dementia, Volume 2: v. 2
95% match

Research Progress in Alzheimer's Disease and Dementia, Volume 2: v. 2

£69.64 09 Jul 2026
Developing Therapeutics for Alzheimer's Disease: Progress and Challenges
95% match

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Academic Press

£90.48 03 Jul 2026
Alzheimer's Disease and Related Disorders: Etiology, Pathogenesis and Therapeutics
95% match

Alzheimer's Disease and Related Disorders: Etiology, Pathogenesis and Therapeutics

Wiley-Blackwell

£139.28 10 Jun 2026
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease
95% match

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Academic Press

£92.39 02 Jul 2026
Alzheimer's Disease Drug Development: Research and Development Ecosystem
95% match

Alzheimer's Disease Drug Development: Research and Development Ecosystem

Cambridge University Press

£54.48 23 Jun 2026
Multi-Factorial Approach as a Therapeutic Strategy for the Management of Alzheimer’s Disease
95% match

Multi-Factorial Approach as a Therapeutic Strategy for the Management of Alzheimer’s Disease

Springer

Price unavailable
Neuroprotection in Alzheimer's Disease
95% match

Neuroprotection in Alzheimer's Disease

Academic Press

£88.59 10 Jul 2026
Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid beta: 38 (Subcellular Biochemistry)
95% match

Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid beta: 38 (Subcellular Biochemistry)

Springer

£161.77 18 Jul 2026
Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4
95% match

Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4

£11.43 04 Jul 2026
Nutraceuticals for Alzheimer's Disease: A Promising Therapeutic Approach (Nutritional Neurosciences)
95% match

Nutraceuticals for Alzheimer's Disease: A Promising Therapeutic Approach (Nutritional Neurosciences)

Springer

£138.70 30 Jun 2026
Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)
95% match

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

CRC Press

£87.80 09 Jul 2026
ALZHEIMER'S DISEASE: INSIGHTS INTO LOW MOLECULAR WEIGHT AND CYTOTOXIC AGGREGATES FROM IN VITRO AND COMPUTER EXPERIMENTS - MOLECULAR BASIS OF ... (Molecular Medicine And Medicinal Chemistry)
95% match

ALZHEIMER'S DISEASE: INSIGHTS INTO LOW MOLECULAR WEIGHT AND CYTOTOXIC AGGREGATES FROM IN VITRO AND COMPUTER EXPERIMENTS - MOLECULAR BASIS OF ... (Molecular Medicine And Medicinal Chemistry)

Imperial College Press

£80.01 30 Jun 2026
Ageing and Dementia (Journal of Neural Transmission. Supplementa): 53
95% match

Ageing and Dementia (Journal of Neural Transmission. Supplementa): 53

Springer

£172.84 13 Jun 2026
Practical Pharmacology for Alzheimer’s Disease
95% match

Practical Pharmacology for Alzheimer’s Disease

Springer

£145.35 14 Jul 2026
The Dementias: Diagnosis, Management, and Research
95% match

The Dementias: Diagnosis, Management, and Research

American Psychiatric Association Publishing

£113.00 18 Jul 2026
Alzheimer’s Disease II: 24 (Topics in Medicinal Chemistry, 24)
95% match

Alzheimer’s Disease II: 24 (Topics in Medicinal Chemistry, 24)

Springer

£142.14 13 Jul 2026
Practical Pharmacology for Alzheimer’s Disease
95% match

Practical Pharmacology for Alzheimer’s Disease

Springer

£76.63 14 Jul 2026
Molecular Biology of Alzheimer's Disease: Genes and Mechanisms Involved in Amyloid Generation
95% match

Molecular Biology of Alzheimer's Disease: Genes and Mechanisms Involved in Amyloid Generation

CRC Press

£260.58 16 Jun 2026
Psychology Press - Clinical Management of Early Alzheimer's Disease
95% match

Psychology Press - Clinical Management of Early Alzheimer's Disease

Psychology Press

£37.21 17 Jul 2026
American Psychiatric Publishing Textbook of Alzheimer Disease and Other Dementias
95% match

American Psychiatric Publishing Textbook of Alzheimer Disease and Other Dementias

American Psychiatric Association Publishing

£95.24 24 Jul 2026